WHO IRIS >
Headquarters >
Governing bodies >
EB130 >

Title: Substandard/spurious/falsely-labelled/falsified/counterfeit medical products
Authors: Executive Board, 130
Keywords: Pharmaceutical products
Resolutions and decisions
Issue Date: 2012
Publisher: World Health Organization
Place of publication: Geneva
Language: English
Description: Executive Board 130th session, agenda item 6.13
Subject: Pharmaceutical Preparations
Drug Contamination
Fraud
Drug Industry
Context: supply and distribution
standards
Gov't Doc #: EB130.R13
URI: http://www.who.int/iris/handle/10665/23855
Appears in Collections:EB130

Files in This Item:

File Description SizeFormat
B130_R13-en.pdf20.96 kBAdobe PDFThumbnail
View/Open

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.